Skip to main content
S.M.A.I.O logo

S.M.A.I.O — Investor Relations & Filings

Ticker · ALSMA ISIN · FR0014005I80 LEI · 969500T1Z0DAZXPZMC93 PA Manufacturing
Filings indexed 116 across all filing types
Latest filing 2026-05-11 Share Issue/Capital Cha…
Country FR France
Listing PA ALSMA

About S.M.A.I.O

https://smaio.com/

S.M.A.I.O. (Software, Machines and Adaptative Implants in Orthopaedics) is a medical device manufacturer that develops solutions for spine surgery. The company provides a comprehensive platform, I-Kontrol, which incorporates planning software, adaptive implants, and related services for spine surgeons. This integrated solution is designed to enhance control over surgical procedures to improve safety, performance, and repeatability. The I-Kontrol platform covers the entire surgical workflow, including pre-operative planning (i-PLAN), surgical execution with implants (i-PERFORM), post-operative outcome analysis (i-CHECK), and training programs (i-LEARN). S.M.A.I.O. utilizes clinical data, imaging, and artificial intelligence to advance the treatment of vertebral conditions.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Share Issue/Capital Change Classification · 75% confidence The document is a press release (“communiqué de presse”) announcing the nomination of Dr. Jeffrey M. Hills to SMAIO’s North American Scientific Council and detailing his remuneration via the issuance of bons de souscription d’actions (BSA). While it includes an advisory appointment, the annexed section focuses on the issuance of warrants, a corporate action involving a new securities issuance under a board‐delegated authorization. This fits the definition of a Share Issue/Capital Change announcement rather than a pure management change or generic regulatory notice. Therefore, the filing is best classified under Share Issue / Capital Change (SHA).
2026-05-11 French
Inside Information / Other news releases
Board/Management Information Classification · 65% confidence The document is a corporate press release announcing the appointment of Dr. Jeffrey M. Hills to SMAIO’s North American Scientific Advisory Board along with details of his remuneration via share subscription warrants. This is an announcement of a change in the company's advisory/management structure, falling under Board/Management Information (MANG).
2026-05-11 English
Inside Information / Other news releases
Regulatory Filings
2026-05-05 English
Informations privilégiées / Autres communiqués
Regulatory Filings
2026-05-05 French
Rapports financiers et d'audit annuels / Modalités de mise à disposition du rapport financier annuel
Report Publication Announcement Classification · 95% confidence The document is a brief press release (3,435 characters) announcing that the company’s annual financial report for 2025 has been made available on its website and Euronext, with no underlying financial data or detailed reporting content included. This fits the “Report Publication Announcement” category under the “menu vs. meal” rule, rather than the full Annual Report itself.
2026-04-27 French
Inside Information / News release on accounts, results
Earnings Release Classification · 90% confidence The document is a press release announcing the company’s full‐year 2025 consolidated financial results, with headline metrics (sales growth, gross margin, EBITDA, cash position) and accompanying commentary. It is not the full Annual Report (10‐K) nor a regulatory notice of publication, but rather the initial financial results announcement. This matches the definition of an Earnings Release (ER). FY 2025
2026-04-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.